These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34048739)

  • 1. Mitochondrial dysfunction and apoptosis are attenuated through activation of AMPK/GSK-3β/PP2A pathway in Parkinson's disease.
    Su J; Zhang J; Bao R; Xia C; Zhang Y; Zhu Z; Lv Q; Qi Y; Xue J
    Eur J Pharmacol; 2021 Sep; 907():174202. PubMed ID: 34048739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teaghrelin protected dopaminergic neurons in MPTP-induced Parkinson's disease animal model by promoting PINK1/Parkin-mediated mitophagy and AMPK/SIRT1/PGC1-α-mediated mitochondrial biogenesis.
    Jhuo CF; Chen CJ; Tzen JTC; Chen WY
    Environ Toxicol; 2024 Jul; 39(7):4022-4034. PubMed ID: 38622810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/MPP-treated neurons.
    Petit-Paitel A; Brau F; Cazareth J; Chabry J
    PLoS One; 2009; 4(5):e5491. PubMed ID: 19430525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-F001, a Multifunction ROCK Inhibitor Prevents 6-OHDA Induced Cell Death Through Activating Akt/GSK-3beta and Nrf2/HO-1 Signaling Pathway in PC12 Cells and Attenuates MPTP-Induced Dopamine Neuron Toxicity in Mice.
    Luo L; Chen J; Su D; Chen M; Luo B; Pi R; Wang L; Shen W; Wang R
    Neurochem Res; 2017 Feb; 42(2):615-624. PubMed ID: 28078613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective Effect of Chlorogenic Acid on Mitochondrial Dysfunction-Mediated Apoptotic Death of DA Neurons in a Parkinsonian Mouse Model.
    Singh SS; Rai SN; Birla H; Zahra W; Rathore AS; Dilnashin H; Singh R; Singh SP
    Oxid Med Cell Longev; 2020; 2020():6571484. PubMed ID: 32566093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
    Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
    Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ROCK1 induces dopaminergic nerve cell apoptosis via the activation of Drp1-mediated aberrant mitochondrial fission in Parkinson's disease.
    Zhang Q; Hu C; Huang J; Liu W; Lai W; Leng F; Tang Q; Liu Y; Wang Q; Zhou M; Sheng F; Li G; Zhang R
    Exp Mol Med; 2019 Oct; 51(10):1-13. PubMed ID: 31578315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
    Pariyar R; Bastola T; Lee DH; Seo J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of miR‑185 inhibits autophagy and apoptosis of dopaminergic neurons by regulating the AMPK/mTOR signaling pathway in Parkinson's disease.
    Wen Z; Zhang J; Tang P; Tu N; Wang K; Wu G
    Mol Med Rep; 2018 Jan; 17(1):131-137. PubMed ID: 29115479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease.
    Zhang L; Huang L; Chen L; Hao D; Chen J
    Toxicol Lett; 2013 Oct; 222(2):155-63. PubMed ID: 23911879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways.
    Park JS; Choe K; Lee HJ; Park TJ; Kim MO
    J Biomed Sci; 2023 Aug; 30(1):66. PubMed ID: 37568205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol attenuates MPP
    Zeng W; Zhang W; Lu F; Gao L; Gao G
    Neurosci Lett; 2017 Jan; 637():50-56. PubMed ID: 27894919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. circSAMD4A participates in the apoptosis and autophagy of dopaminergic neurons via the miR‑29c‑3p‑mediated AMPK/mTOR pathway in Parkinson's disease.
    Wang W; Lv R; Zhang J; Liu Y
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34080649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of glycogen synthase kinase-3β with Parkinson's disease (review).
    Li DW; Liu ZQ; Chen W; Yao M; Li GR
    Mol Med Rep; 2014 Jun; 9(6):2043-50. PubMed ID: 24681994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B.
    Guo B; Hu S; Zheng C; Wang H; Luo F; Li H; Cui W; Yang X; Cui G; Mak S; Choi TC; Ma ED; Wang Y; Lee SMY; Zhang Z; Han Y
    Neuropharmacology; 2017 Nov; 126():12-24. PubMed ID: 28807675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of protocatechuic aldehyde through PLK2/p-GSK3β/Nrf2 signaling pathway in both
    Guo C; Zhu J; Wang J; Duan J; Ma S; Yin Y; Quan W; Zhang W; Guan Y; Ding Y; Wen A; Zhang Y
    Aging (Albany NY); 2019 Nov; 11(21):9424-9441. PubMed ID: 31697645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
    Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY
    Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease.
    Golpich M; Amini E; Hemmati F; Ibrahim NM; Rahmani B; Mohamed Z; Raymond AA; Dargahi L; Ghasemi R; Ahmadiani A
    Pharmacol Res; 2015 Jul; 97():16-26. PubMed ID: 25829335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
    Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.